PREDICTIVE ONCOLOGY INC's ticker is and the CUSIP is 74039M200. A total of 13 filers reported holding PREDICTIVE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $695,443 | +6.6% | 2,128,039 | 0.0% | 0.00% | – |
| Q4 2022 | $652,457 | -14.7% | 2,128,039 | +0.1% | 0.00% | – |
| Q3 2022 | $765,000 | -12.3% | 2,126,663 | 0.0% | 0.00% | – |
| Q2 2022 | $872,000 | -58.0% | 2,126,663 | 0.0% | 0.00% | – |
| Q1 2022 | $2,078,000 | +2.7% | 2,126,663 | 0.0% | 0.00% | – |
| Q4 2021 | $2,024,000 | -24.0% | 2,126,663 | +6.3% | 0.00% | – |
| Q3 2021 | $2,662,000 | +10.5% | 2,001,229 | +8.9% | 0.00% | – |
| Q2 2021 | $2,408,000 | +259.4% | 1,838,085 | +231.9% | 0.00% | – |
| Q1 2021 | $670,000 | +155.7% | 553,759 | +54.6% | 0.00% | – |
| Q4 2020 | $262,000 | +15.4% | 358,289 | +28.6% | 0.00% | – |
| Q3 2020 | $227,000 | +305.4% | 278,567 | +708.6% | 0.00% | – |
| Q2 2020 | $56,000 | +55.6% | 34,451 | +50.6% | 0.00% | – |
| Q1 2020 | $36,000 | -35.7% | 22,881 | +6.7% | 0.00% | – |
| Q4 2019 | $56,000 | – | 21,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fusion Capital, LLC | 12,000 | $16,000 | 0.01% |
| Csenge Advisory Group | 22,500 | $29,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 48,166 | $63,000 | 0.00% |
| Private Advisor Group, LLC | 26,805 | $35,000 | 0.00% |
| NewSquare Capital LLC | 2,500 | $3,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 10,091 | $13,000 | 0.00% |
| Focused Wealth Management, Inc | 200 | $0 | 0.00% |
| UBS Group AG | 3,675 | $5,000 | 0.00% |
| Squarepoint Ops LLC | 25,348 | $33,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 6,920 | $10,000 | 0.00% |